A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis.
Nobuyasu IshiiToshiki ShimizuYoshihisa IshiuraHideki AmuroTohru NishizawaTakeshi TamakiShosaku NomuraPublished in: Journal of inflammation research (2021)
These data clearly demonstrate that the baseline value of CRP was closely associated with long time DCT in patients of RA treated with TCZ.